FDI deals so far in 2017 have almost doubled on year to $7.1 billion, the State Council said it would more than halve the number of drug distributors to cut pharmaceutical prices, and the PBOC has run trials of its new cryptocurrency
The CSRC has clamped down on excess fundraising by listed companies, AMAC has curbed property speculation in the securities market and the new catalogue further opens central and western China up to high-tech FDI